1. Home
  2. JKS vs RAPP Comparison

JKS vs RAPP Comparison

Compare JKS & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JinkoSolar Holding Company Limited (each representing 4)

JKS

JinkoSolar Holding Company Limited (each representing 4)

HOLD

Current Price

$24.73

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$39.15

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
JKS
RAPP
Founded
2006
2022
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2010
2024

Fundamental Metrics

Financial Performance
Metric
JKS
RAPP
Price
$24.73
$39.15
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$24.80
$48.50
AVG Volume (30 Days)
691.0K
329.7K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
6.04%
N/A
EPS Growth
N/A
24.34
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.53
$7.73
52 Week High
$31.88
$42.27

Technical Indicators

Market Signals
Indicator
JKS
RAPP
Relative Strength Index (RSI) 56.51 65.60
Support Level $23.78 $25.48
Resistance Level $26.67 $41.59
Average True Range (ATR) 1.24 2.05
MACD 0.31 0.17
Stochastic Oscillator 88.45 79.98

Price Performance

Historical Comparison
JKS
RAPP

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: